Trials / Conditions / Stage IIIA Non-Small Cell Lung Cancer AJCC v7

Stage IIIA Non-Small Cell Lung Cancer AJCC v7

11 registered clinical trials studyying Stage IIIA Non-Small Cell Lung Cancer AJCC v7.

Status	Trial	Sponsor	Phase
Terminated	Anetumab Ravtansine and Atezolizumab in Treating Participants With Advanced Non-small Cell Lung Cancer NCT03455556	Mayo Clinic	Phase 1
Terminated	Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell NCT03348748	Roswell Park Cancer Institute	EARLY_Phase 1
Terminated	Collection of Blood Samples in Patients With Non-small Cell Lung Cancer NCT03492801	University of Southern California	—
Completed	Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malig NCT03229278	Rutgers, The State University of New Jersey	Phase 1
Terminated	Genetically Modified T Cells in Treating Patients With Stage III-IV Non-small Cell Lung Cancer or Mesothelioma NCT02408016	Fred Hutchinson Cancer Center	Phase 1 / Phase 2
Completed	Cisplatin, Docetaxel, and Nintedanib Before Surgery in Treating Patients With Previously Untreated Stage IB-II NCT02225405	M.D. Anderson Cancer Center	Phase 1
Active Not Recruiting	Crizotinib in Treating Patients With Stage IB-IIIA Non-small Cell Lung Cancer That Has Been Removed by Surgery NCT02201992	ECOG-ACRIN Cancer Research Group	Phase 3
Active Not Recruiting	Comparing Photon Therapy To Proton Therapy To Treat Patients With Lung Cancer NCT01993810	Radiation Therapy Oncology Group	Phase 3
Terminated	Erlotinib Hydrochloride or Crizotinib and Chemoradiation Therapy in Treating Patients With Stage III Non-small NCT01822496	National Cancer Institute (NCI)	Phase 2
Completed	Recombinant Interleukin-15 in Treating Patients With Advanced Melanoma, Kidney Cancer, Non-small Cell Lung Can NCT01727076	National Cancer Institute (NCI)	Phase 1
Active Not Recruiting	Image-Guided, Intensity-Modulated Photon or Proton Beam Radiation Therapy in Treating Patients With Stage II-I NCT01629498	M.D. Anderson Cancer Center	Phase 1 / Phase 2